| [1] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2015, 2016, 66(2):115-132.
|
| [2] |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016[J]. CA Cancer J Clin, 2016, 66(1):7-30.
|
| [3] |
Bizama C, García P, Espinoza JA, et al. Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapy[J]. Cancer Treat Rev, 2015, 41(3):222-234.
|
| [4] |
Li ML, Zhang Z, Li XG, et al. Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway[J]. Nat Genet, 2014, 46(8):872-876.
|
| [5] |
Alioa TA, Járufe N, Javle M, et al. Gallbladder cancer: expert consensus statement[J]. HPB, 2015, 17(8):681-690.
|
| [6] |
Pilgrim CH, Groeschl RT, Christians KK, et al. Modern perspectives on factors predisposing to the development of gallbladder cancer[J]. HPB, 2013, 15(11):839-844.
|
| [7] |
Piehler JM, Crichlow RW. Primary carcinoma of the gallbladder[J]. Surg Gynecol Obstet, 1978, 147(6):929-942.
|
| [8] |
Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer[J]. Gut Liver, 2012, 6(2):172-187.
|
| [9] |
Schnelldorfer T. Porcelain gallbladder: a benign process or concern for malignancy?[J]. J Gastrointest Surg, 2013, 17(6):1161-1168.
|
| [10] |
Gonzalez-Escobedo G, Marshall JM, Gunn JS. Chronic and acute infection of the gall bladder by Salmonella typhi: understanding the carrier state[J]. Nat Rev Microbiol, 2011, 9(1):9-14.
|
| [11] |
Hundal R, Shaffer EA. Gallbladder cancer: epidemiologyand outcome[J]. Clin Epidemiol, 2014, 6(6):99-109.
|
| [12] |
Pandey M. Risk factors for gallbladder cancer: a reappraisal[J]. Eur J Cancer Prev, 2003, 12(1):15-24.
|
| [13] |
Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors[J].Int J Cancer, 2006, 118(7):1591-1602.
|
| [14] |
Wolin KY, Carson K, Colditz GA. Obesity and cancer[J]. Oncologist, 2010, 15(6):556-565.
|
| [15] |
Lai HC, Chang SN, Lin CC, et al. Does diabetes mellitus with or without gallstones increase the risk of gallbladder cancer? results from a population-based cohort study[J]. J Gastroenterol, 2013, 48(7):856-865.
|
| [16] |
Kuzmickiene I, Didziapetris R, Stukonis M. Cancer incidence in the workers cohort of textile manufacturing factory in Alytus, Lithuania[J]. J Occup Environ Med, 2004, 46(2):147-153.
|
| [17] |
Wernberg JA, Lucarelli DD. Gallbladder cancer[J]. Surg Clin North Am, 2014, 94(2):343-360.
|
| [18] |
Javle M, Bekaii-Saab T, Jain A, et al. Biliary cancer: utility of next generation sequencing for clinical management[J]. Cancer, 2016, 122(24):3838-3847.
|
| [19] |
Kumari N, Corless CL, Warrick A, et al. Mutation profiling in gallbladder cancer in Indian population[J]. Indian J Pathol Microbiol, 2014, 57(1):9-12.
|
| [20] |
Saetta AA, Papanastasiou P, Michalopoulos NV, et al. Mutational analysis of BRAF in gallbladder carcinomas in association with K-ras and p53 mutations and microsatellite instability[J]. Virchows Arch, 2004, 445(2):179-182.
|
| [21] |
Wistuba II, Miquel JF, Gazdar AF, et al. Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas[J]. Hum Pathol, 1999, 30(1):21-25.
|
| [22] |
Goldin RD, Roa JC. Gallbladder cancer: a morphological and molecular update[J]. Histopathology, 2009, 55(2):218-229.
|
| [23] |
Singh MK, Chetri K, Pandey UB, et al. Mutational spectrum of K-ras oncogene among Indian patients with gallbladder cancer[J].J Gastroenterol Hepatol, 2004, 19(8):916-921.
|
| [24] |
Quan ZW, Wu K, Wang J, et al. Association of p53, p16, and vascular endothelial growth factor protein expressions with the prognosisand metastasis of gallbladder cancer[J]. J Am Coll Surg, 2001, 193(4): 380-383.
|
| [25] |
Moy AP, Shahid M, Ferrone CR, et al. Microsatellite instability in gallbladder carcinoma[J]. Virchow Arch, 2015, 466(4):393-402.
|
| [26] |
Mishra PK, Raghuram GV, Jatawa SK, et al. Frequency of genetic alerations observed in cell cycle regulatory proteins and microsatellite instability in gallbladder adenocarcinoma:a translational perspective[J]. Asian Pac J Cancer Prev, 2011, 12(2): 573-574.
|
| [27] |
Chang Y, Liu C, Yang J, et al. miR-20a triggers metastasis of gallbladder carcinoma[J]. J Hepatol, 2013, 59(3):518-527.
|
| [28] |
Qiu Y, Luo X, Kan T, et al. TGF-β upregulates miR-182 expression to promote gallbladder cancer metastasis by targeting CADM1[J]. Mol Biosyst, 2014, 10(3):679-685.
|
| [29] |
Peng HH, Zhang Y, Gong LS, et al. Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma[J]. Onco Targets Ther, 2013(6):1625-1630.
|
| [30] |
Zhou H, Guo W, Zhao Y, et al. MicroRNA-135a acts as a putative tumor suppressor by directly targeting VLDLR in human gallbladder cancer[J]. Cancer Sci, 2014, 105(8):956-965.
|
| [31] |
Wang SH, Wu XC, Zhang MD, et al. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5P targeting AKT2[J]. Tumor Biol, 2016, 37(7):9721-9730.
|
| [32] |
Shi SJ, Wang LJ, Wang GD, et al. B7-H1 expression is associated with poor prognosis in colorectal carcinoma and regulates the proliferation and invasion of HCT116 colorectal cancer cells[J]. PLoS One, 2013, 8(10):e76012.
|
| [33] |
Neyaz A, Husain N, Kumari S, et al. Clinical relevance of PD-L1 expression in gallbladder cancer: a potential target for therapy[J]. Histopathology, 2018, 73(4):622-633.
|
| [34] |
Li ML, Liu FT, Zhang F, et al. Genomic ERBB2/ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer:a whole-exome sequencing analysis[J]. Gut, 2019, 68(6):1024-1033.
|